Cargando…

Imaging for Cardiovascular Complications of COVID-19: Cardiac Manifestations in Context

After the first confirmed case in 2019, COVID-19 rapidly spread worldwide and overwhelmed the medical community. In the intervening time, we have learned about COVID-19’s clinical manifestations and have developed effective therapies and preventative vaccines. Severe COVID-19 infection is associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Crosier, Rebecca, Kafil, Tahir S., Paterson, D. Ian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Canadian Cardiovascular Society. Published by Elsevier Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886397/
https://www.ncbi.nlm.nih.gov/pubmed/36731604
http://dx.doi.org/10.1016/j.cjca.2023.01.022
Descripción
Sumario:After the first confirmed case in 2019, COVID-19 rapidly spread worldwide and overwhelmed the medical community. In the intervening time, we have learned about COVID-19’s clinical manifestations and have developed effective therapies and preventative vaccines. Severe COVID-19 infection is associated with many cardiovascular disorders in the acute phase, and patients recovered from illness can also manifest long-term sequelae, including long COVID syndrome. Furthermore, severe acute respiratory syndrome–related coronavirus-2 messenger RNA (mRNA) vaccination can trigger rare cases of myopericarditis. We have gained significant knowledge of the acute and long-term cardiovascular complications of COVID-19– and mRNA vaccine–associated myocarditis through clinical and investigative studies using cardiac imaging. In this review, we describe how cardiovascular imaging can be used to understand the cardiovascular complications and cardiac injury associated with acute COVID-19 infection, review the imaging findings in patients recovered from illness, and discuss the role and limitations of cardiac imaging in COVID-19 mRNA vaccine–associated myocarditis.